This article has Open Peer Review reports available.
Cilostazol as an add-on therapy for patients with Alzheimer’s disease in Taiwan: a case control study
© The Author(s). 2017
Received: 16 August 2016
Accepted: 19 January 2017
Published: 23 February 2017
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|16 Aug 2016||Submitted||Original manuscript|
|22 Sep 2016||Reviewed||Reviewer Report - Carina Wattmo|
|3 Oct 2016||Reviewed||Reviewer Report - Zhao Qianhua|
|20 Nov 2016||Author responded||Author comments - Shu-Yu Tai|
|Resubmission - Version 2|
|20 Nov 2016||Submitted||Manuscript version 2|
|21 Dec 2016||Reviewed||Reviewer Report - Zhao Qianhua|
|13 Jan 2017||Author responded||Author comments - Shu-Yu Tai|
|Resubmission - Version 3|
|13 Jan 2017||Submitted||Manuscript version 3|
|19 Jan 2017||Editorially accepted|
|23 Feb 2017||Article published||10.1186/s12883-017-0800-y|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.